Intuitive Surgical (NASDAQ:ISRG) Given New $650.00 Price Target at Truist Financial

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by stock analysts at Truist Financial from $620.00 to $650.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price objective would suggest a potential upside of 15.48% from the company’s current price.

A number of other research firms also recently commented on ISRG. HSBC raised their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. BTIG Research boosted their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn lifted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $611.08.

Intuitive Surgical Trading Up 1.1%

Shares of ISRG traded up $5.99 during mid-day trading on Thursday, reaching $562.85. The company had a trading volume of 81,346 shares, compared to its average volume of 2,076,956. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a fifty day simple moving average of $536.26 and a 200-day simple moving average of $505.77. The stock has a market cap of $201.77 billion, a price-to-earnings ratio of 74.31, a price-to-earnings-growth ratio of 5.10 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the company posted $1.84 EPS. The business’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. This trade represents a 77.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 114,007 shares of company stock worth $63,533,844 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Tobam lifted its stake in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $27,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. TD Capital Management LLC lifted its position in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.